TdT positive childhood acute lymphoblastic leukemia
Showing 1 - 25 of >10,000
B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)
Recruiting
- B-Cell Lymphoblastic Leukemia
- Acute Lymphoblastic Leukemia
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2023
Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Low-field magnetic resonance imaging
- +3 more
-
Erlangen, Bavaria, GermanyDepartment of Pediatrics and Adolescent Medicine
Oct 23, 2023
Acute Lymphoblastic Leukemia Trial in Saint Louis (Family-based Behavioral Weight Loss Treatment)
Recruiting
- Acute Lymphoblastic Leukemia
- Family-based Behavioral Weight Loss Treatment
-
Saint Louis, MissouriWashington University School of Medicine
Jan 17, 2023
Severe Toxicity Free Survival Following Childhood Acute
Recruiting
- Acute Lymphoblastic Leukemia
-
Copenhagen, DenmarkKjeld Schmiegelow
Dec 9, 2022
Acute Lymphoblastic Leukemia, Pediatric Trial in Bratislava (Lacticaseibacillus paracasei subsp. Paracasei CNCMI-1518, Physical
Recruiting
- Acute Lymphoblastic Leukemia, Pediatric
- Lacticaseibacillus paracasei subsp. Paracasei CNCMI-1518
- Physical exercise
-
Bratislava, SlovakiaDepartment of Pediatric Hematology National Institute of Childre
Jul 12, 2023
KCTD Protein Family in Clinical Management of Childhood Acute
Recruiting
- Childhood Acute Lymphoblastic Leukemia
- observational study
-
Naples, ItalyIRCCS Synlab SDN
Feb 6, 2023
Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia Trial
Completed
- Acute Undifferentiated Leukemia
- +13 more
- allopurinol
- +16 more
-
Chicago, IllinoisCancer and Leukemia Group B
Apr 5, 2022
Acute Lymphoblastic Leukemia, Obesity Trial in New York (PEDALL, Standard of care)
Recruiting
- Acute Lymphoblastic Leukemia
- Obesity
- PEDALL
- Standard of care
-
New York, New YorkColumbia University Medical Center
Jul 19, 2023
Acute Lymphoid Leukemia Trial in Seoul (Blincyto)
Not yet recruiting
- Acute Lymphoid Leukemia
-
Seoul, Gangnam-gu, Korea, Republic of
- +4 more
Apr 12, 2023
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Recruiting
- Recurrent Childhood Acute Myeloid Leukemia
- +17 more
-
Miami, FloridaNicklaus Children's Hospital
May 13, 2023
Optimize the Maintenance Phase of Childhood ALL
Recruiting
- Acute Lymphoblastic Leukemia
-
Trieste, ItalyIRCCS materno infantile Burlo Garofolo
Mar 31, 2023
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Completed
- Recurrent Childhood Acute Myeloid Leukemia
- +13 more
-
Miami, FloridaNicklaus Children's Hospital
Jan 18, 2023
DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
- +8 more
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Jul 12, 2022
Acute Lymphoblastic Leukemia (ALL) Trial (Nilotinib)
No longer available
- Acute Lymphoblastic Leukemia (ALL)
- (no location specified)
Aug 5, 2022
Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in
Suspended
- Juvenile Myelomonocytic Leukemia
- +27 more
- CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2023
Tumor Tissue Samples From Young Acute Lymphoblastic Leukemia
Completed
- Childhood Acute Lymphoblastic Leukemia in Remission
- Recurrent Childhood Acute Lymphoblastic Leukemia
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Aug 12, 2022
Oral Mucositis, Childhood Acute Lymphoblastic Leukemia Trial (Laser Therapy, Sham procedure)
Not yet recruiting
- Oral Mucositis
- Childhood Acute Lymphoblastic Leukemia
- Laser Therapy
- Sham procedure
- (no location specified)
Jul 7, 2022
Acute Lymphoblastic Leukemia Trial (inotuzumab ozogamicin)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- inotuzumab ozogamicin
- (no location specified)
Jan 6, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +7 more
- Blinatumomab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Acute Lymphoblastic Leukemia Trial in Sanhe (CAR-NK-CD19 Cells)
Completed
- Acute Lymphoblastic Leukemia
- CAR-NK-CD19 Cells
-
Sanhe, Hebei, ChinaHebei Yanda Ludaopei Hospital
Nov 24, 2022
Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)
Recruiting
- Acute Lymphoblastic Leukemia
- Dasatinib
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Nov 28, 2022
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
Recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- No intervention
-
New York, New York
- +6 more
Jun 24, 2023
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic
Active, not recruiting
- Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +6 more
- Dexamethasone
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 2, 2022
Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Positive Trial in New York (Blinatumomab, dasatinib, dexamethasone)
Recruiting
- Acute Lymphoblastic Leukemia
- Philadelphia Chromosome-Positive
- Blinatumomab
- +3 more
-
New York, New York
- +1 more
Nov 10, 2022
Blasts 5 Percent or More of Bone Marrow Nucleated Cells, CD22 Positive, Philadelphia Chromosome Positive Trial in Monrovia,
Recruiting
- Blasts 5 Percent or More of Bone Marrow Nucleated Cells
- +4 more
- ADCT-602
-
Monrovia, California
- +1 more
Dec 7, 2022